Evidence map›Paper›PMID 40098198›Full record

ReviewChinese medicine2025

New advances in Traditional Chinese Medicine interventions for epilepsy: where are we and what do we know?

Minjuan Sun, Xiaoyun Qiu, Zhijian Yuan, Cenglin Xu, Zhong Chen

Abstract readReview
In one paragraph

Review in Chinese medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Electroacupuncture-based vagal stimulation attenuates epileptic seizures through a body-brain circuit.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Minjuan Sun *Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, Huzhou Central Hospital, the Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Xiaoyun Qiu *Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, Huzhou Central Hospital, the Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Zhijian YuanKey Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, Huzhou Central Hospital, the Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Cenglin XuKey Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, Huzhou Central Hospital, the Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. xucenglin5zz@zju.edu.cn.
Zhong ChenKey Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, Huzhou Central Hospital, the Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. chenzhong@zju.edu.cn.

Funding

the National Natural Science Foundation of China 82173796the National Natural Science Foundation of China 82374064the Natural Science Foundation of Zhejiang Province LQ24H310006
6 · The paper itself

Abstract

Epilepsy, one of the most common neurological diseases, affects more than 70 million people worldwide. Anti-seizure drugs targeting membrane ion channels or GABAergic neurotransmission are the first choices for controlling seizures, whereas the high incidence of pharmacoresistance and adverse effects largely restrict the availability of current anti-seizure drugs (ASDs). Traditional Chinese Medicine (TCM) has shown historical evidence-based therapeutic effects for neurological diseases including epilepsy. But until the late 1990s, great efforts in both clinical and experimental fields advanced TCM interventions for epilepsy from evidence-based practices to more systematic neuropharmacological significance, and show new lights on preferable management of epilepsy in the last decade. This review summarized the advances of applying TCM interventions (ranging from herbal medicines and their active ingredients to other strategies such as acupuncture) for epilepsy, followed by associated mechanism theories. The therapeutic potential of TCM interventions for epilepsy as well as its comorbidities turns from somehow debatable to hopeful. Finally, some prospects and directions were proposed to drive further clinical translational research. The future directions of TCM should aim at not only deriving specific anti-epileptic molecules but also illustrating more precise mechanisms with the assistance of advanced multifaceted experimental tools.

Indexed as

AcupunctureEpilepsyEpileptic comorbiditiesHerbal medicinePrescriptionTraditional Chinese Medicine

Identifiers

PMID40098198
PMCPMC11917061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.